User: prashantiyengar Topic: IP
Category: drugs :: india
Last updated: May 25 2015 06:36 IST RSS 2.0
 
1 to 20 of 2,571    
Lupin plans cancer drug unit in Mihan 25.5.2015 Nagpur News, Nagpur City News | Cities News - Times of India
Lupin plans cancer drug unit in Mihan
Also found in: [+]
Suven Life Sciences gets patents for neurodegenerative drug 22.5.2015 TOI: India Business
Biopharmaceutical firm Suven Life Sciences on Friday said it has been granted one patent each by Mexico and Singapore for a drug used in the treatment of neurodegenerative diseases.
Also found in: [+]
India eyes 15% jump in medicine exports this fiscal 21.5.2015 ET: Healthcare
Indian drug makers are hopeful of achieving double digit growth in exports this fiscal after being confined to single digit growth for two years.
Also found in: [+]
UPDATE 1-Indian court bars Glenmark from selling Merck drug copies 15.5.2015 Sify Finance
(Adds details from court order)
Also found in: [+]
Supreme Court bars Glenmark from selling Merck drug copies 15.5.2015 Sify Finance
MUMBAI (Reuters) - The Supreme Court of India has barred Glenmark Pharmaceuticals from making and selling copies of U.S. drugmaker Merck's diabetes drugs Januvia and Janumet,
Also found in: [+]
Suven Life Sciences gets patents for neurological drug 13.5.2015 TOI: India Business
Pharmaceutical firm Suven Life Sciences on Wednesday said it has been granted one patent each by Europe and Hong Kong for a drug used in the treatment of neurodegenerative diseases.
Also found in: [+]
Awareness about AYUSH 8.5.2015 Govt of india: PIB
National Sample Survey Office (NSSO) in their 68th round (July 2011-June 2012) on socio economic household surveys has collected information on awareness and acceptability of AYUSH.
Also found in: [+]
US pharma sector welcomes India's intellectual property policy 6.5.2015 ET: Pharma
The US pharma sector has welcomed India's recent moves on intellectual property, including bringing out a draft policy and sustained engagement.
Also found in: [+]
India fully aligned with international IPR, will safeguard its own interests, says Nirmala Sitharaman 4.5.2015 ET: Policy
Different arms of the government are not speaking the same language on IPR, which is leading to confusion on where India stands on these issues.
Also found in: [+]
USTR’s praise of Modi’s remarks worries pharma companies 2.5.2015 TOI: India Business
The United States’ appreciation of Prime Minister Narendra Modi’s remarks on intellectual property rights (IPR) has stirred concerns among the public health groups as well as the domestic drug manufacturing industry.
Also found in: [+]
Talks on India-European Free Trade Association pact stuck over IPR issues 1.5.2015 ET: Foreign Trade
According to the Ministry of Commerce data, India's exports to Switzerland was USD 1.8 billion in 2013-14 and imports were USD 19.3 billion for the same period.
Also found in: [+]
Indian biotech firm Stempeutics Research gets China Patent for its novel stem cell drug 25.4.2015 ET: Biotech
Stempeutics' stem cell-based drugs enable living tissues to repair or replace tissue or organ function lost due to age, disease, damage or congenital defects.
Also found in: [+]
Fears over EU plan for strict drug patent regime 14.4.2015 TOI: Home
As Prime Minister Narendra Modi and German Chancellor Markel are set to discuss the India-EU free trade agreement, public health groups and Indian pharmaceutical companies are concerned that the European Commission may push for stringent patent regime for cheaper medicines manufactured at home.
Also found in: [+]
What India Inc can learn from IBM 10.4.2015 ET: Corporate Dossier
IBM's global research head Arvind Krishna on its patents factory, innovation engine and working with Nobel laureates.
Also found in: [+]
Sensex, Nifty caught in tight band; Sun Pharma gains 4.5% 6.4.2015 Sify Finance
Also found in: [+]
Pharma companies dominate 2014 list of Indian firms filing for global patents 4.4.2015 TOI: India Business
Led by companies such as Ranbaxy, Wockhardt and Hetero, the pharma sector dominates the list of top Indian filers under the Patent Cooperation Treaty (PCT) in 2014, seeking protection internationally for their inventions.
Also found in: [+]
Compulsory licensing hit India’s image: Hetero Pharma 31.3.2015 ET: Pharma
Hyderabadbased Hetero Pharma said that the country has lost nearly $10 billion worth of investment by not respecting IP norms.
Also found in: [+]
Stada agrees oncology deal with Indian Hetero Drugs 26.3.2015 Sify Finance
FRANKFURT (Reuters) - German generic drugmaker Stada struck an alliance with family-owned Hetero Drugs Ltd of India to gain access to active ingredients for cancer drugs, Stada said on Thursday.
Also found in: [+]
CAG slams Kerala Ayurveda company for laxity in manufacturing 26.3.2015 ET: Healthcare
The report also said the company admitted that it has the facility to test only microbial and physico-chemical parametres of products.
Also found in: [+]
SC stays HC order restraining firm from manufacturing anti-diabetes drugs 26.3.2015 TOI: India
The Supreme Court on Wednesday stayed a Delhi High Court order restraining Indian pharma company Glenmark Pharmaceuticals from manufacturing and selling its anti-diabetes drugs Zita and Zita-Met for allegedly infringing the patent rights of US drug major Merck Sharp and Dohme ...
Also found in: [+]
1 to 20 of 2,571